🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Reduced nitric oxide (NO) availability is a hallmark of a number of cardiov...
Status
Unknown
Location
Multiple Locations
Start Date
2016-10
Trial ID
NCT02934438
The nitric oxide supplementation product, Neo40 Daily®, provides a dietary ...
Status
Completed
Location
Hypertension Institute
Start Date
2017-04-05
Trial ID
NCT03895749
Treatments Being Tested
Acute supplementation of Neo40(TM), a nitrate lozenge, will improve cycling...
Status
Unknown
Location
The University of Texas at Austin
Start Date
2012-10
Trial ID
NCT01710761
Treatments Being Tested
This study will investigate the effect of a nitric oxide supplementation pr...
Status
Terminated
Location
KGK Synergize Inc.
Start Date
2016-02-03
Trial ID
NCT02679248
Treatments Being Tested
This study is designed to compare recovery times after reversal of a residu...
Status
Completed
Location
Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München
Start Date
2009-03
Trial ID
NCT01006720
Treatments Being Tested
This study is designed to compare recovery times after reversal of a residu...
Status
Completed
Location
Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München
Start Date
2009-03
Trial ID
NCT00895609
Treatments Being Tested
Oral supplementation of Neo40(TM), a nitrate lozenge, will reduce blood pre...
Status
Unknown
Location
California Medical Institute
Start Date
2013-01
Trial ID
NCT01937754
Treatments Being Tested